Physician profile
Marshall Tolbert
NPI 1982614988
$7,655.00
in general payments reported to CMS, 2019-2025
15 companies · $1,868 in 2025
The $1,868 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,159 · 2020: $921 · 2021: $1,598 · 2022: $557 · 2023: $938 · 2024: $614 · 2025: $1,868.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,855 · Travel and Lodging: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,854.66 |
| Travel and Lodging | $565.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,100.67 | 2021-2025 | Cd Horizon Spinal System, Mazor X System, Catalyft Pl Expandable Interbody System |
| Globus Medical, INC. | $759.08 | 2019-2025 | Senza |
| Medtronic USA, INC. | $752.34 | 2019-2020 | |
| Abbott Laboratories | $699.52 | 2019-2025 | Eterna, Proclaim |
| Ceribell, INC. | $448.65 | 2020-2022 | |
| Accuray Incorporated | $295.82 | 2023-2024 | Cyberknife System |
| Goode Surgical INC | $172.54 | 2025 | |
| Stryker Corporation | $141.68 | 2019-2021 | |
| Boston Scientific Corporation | $73.95 | 2020-2025 | General - Therapies, Patient Trial Kit |
| Nuvasive, INC. | $72.58 | 2020 | |
| Integra Lifesciences Corporation | $46.31 | 2019-2020 | |
| Alphatec Spine, INC | $36.87 | 2021 | |
| Nevro Corp. | $32.56 | 2024 | Senza |
| Covidien LP | $11.34 | 2020 | |
| Kci USA, INC. | $11.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marshall Tolbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.